MediPal Holdings Corporation (TYO:7459)
Japan · Delayed Price · Currency is JPY 2,927.50
+18.50 (0.64%)
Aug 26, 2026, 10:33 AM JST
MediPal Holdings Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 3,861,698 | 3,817,354 | 3,671,328 | 3,558,732 | 3,360,008 | 3,290,921 |
Revenue Growth | 4.17% | 3.98% | 3.16% | 5.91% | 2.10% | 2.48% |
Gross Profit Gross Profit Growth | 262,043 | 260,988 | 255,759 | 246,655 | 224,305 | 217,445 |
Operating Income Operating Income Growth | 52,513 | 53,184 | 55,611 | 47,331 | 48,974 | 45,625 |
Net Income Net Income Growth | 46,594 | 42,534 | 40,279 | 41,474 | 38,806 | 29,423 |
Earnings Per Share EPS Growth | 227.21 | 206.67 | 193.19 | 195.83 | 179.12 | 131.41 |
EPS Growth | 15.65% | 6.98% | -1.35% | 9.33% | 36.31% | 23.04% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cosmetics, Daily Necessities, and Over-The-Counter Pharmaceutical Wholesale Business Cosmetics, Daily Necessities, and Over-The-Counter Pharmaceutical Wholesale Business Growth | 1,248,726 | 1,237,846 | 1,188,097 | 1,151,966 | 1,104,152 | 1,045,735 |
Businesses Related to the Wholesale of Veterinary Drugs and Raw Materials for Food Processing Businesses Related to the Wholesale of Veterinary Drugs and Raw Materials for Food Processing Growth | 120,319 | 117,328 | 116,861 | 114,023 | 73,954 | 71,858 |
Wholesale Business of Medical Pharmaceuticals and Related Products Wholesale Business of Medical Pharmaceuticals and Related Products Growth | 2,496,664 | 2,466,109 | 2,370,245 | 2,295,795 | 2,189,667 | 2,177,002 |
Unallocated Adjustment Unallocated Adjustment Growth | -4,011 | -3,930 | -3,876 | -3,051 | -7,766 | -3,675 |
Total Total Growth | 3,861,698 | 3,817,353 | 3,671,327 | 3,558,733 | 3,360,007 | 3,290,920 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 289,923 | 289,073 | 261,407 | 230,470 | 195,031 | 261,920 |
Total Debt Total Debt Growth | - | - | - | - | - | 30,078 |
Net Cash (Debt) Net Cash Growth | 289,923 | 289,073 | 261,407 | 230,470 | 195,031 | 231,842 |
Net Cash Growth | 17.84% | 10.58% | 13.42% | 18.17% | -15.88% | 9.91% |
Net Cash Per Share Net Cash Per Share Growth | 1413.76 | 1404.60 | 1253.81 | 1088.23 | 901.48 | 1039.08 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 46,552 | 60,559 | 61,843 | 16,146 | 61,216 |
Capital Expenditures CapEx Growth | - | -6,619 | -8,861 | -15,560 | -10,483 | -15,958 |
Free Cash Flow Free Cash Flow Growth | - | 39,933 | 51,698 | 46,283 | 5,663 | 45,258 |
Free Cash Flow Growth | - | -22.76% | 11.70% | 717.29% | -87.49% | 109.47% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 6.79% | 6.84% | 6.97% | 6.93% | 6.68% | 6.61% |
Operating Margin | 1.36% | 1.39% | 1.52% | 1.33% | 1.46% | 1.39% |
Pretax Margin | 2.25% | 2.14% | 2.09% | 2.10% | 2.09% | 1.74% |
Profit Margin | 1.21% | 1.11% | 1.10% | 1.17% | 1.16% | 0.89% |
FCF Margin | - | 1.05% | 1.41% | 1.30% | 0.17% | 1.38% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 88.000 | 66.000 | 62.000 | 60.000 | 46.000 | 44.000 |
Dividend Per Share Growth | 21.88% | 6.45% | 3.33% | 30.44% | 4.54% | 4.76% |
Dividend Yield | 3.02% | 2.25% | 2.72% | 2.72% | 2.74% | 2.41% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 12.80 | 14.14 | 12.06 | 11.75 | 9.76 | 14.38 |
Forward PE | 13.11 | 15.80 | 13.36 | 13.87 | 12.15 | 13.42 |
P/FCF Ratio | 14.91 | 15.06 | 9.39 | 10.53 | 66.89 | 9.35 |
PS Ratio | 0.15 | 0.16 | 0.13 | 0.14 | 0.11 | 0.13 |